Association between phosphate removal and markers of bone turnover in haemodialysis patients

被引:26
|
作者
Albalate, Marta
de la Piedra, Concepcion
Fernandez, Cristina
Lefort, Mar
Santana, Henar
Hernando, Paloma
Hernandez, Jesus
Caramelo, Carlos
机构
[1] Univ Autonoma Madrid, Hosp Clin, Serv Nefrol & Bioquim, Fdn Jimenez Diaz, Madrid, Spain
[2] Univ Autonoma Madrid, Hosp Clin, Serv Epidemiol, Madrid, Spain
[3] Univ Complutense Madrid, Madrid, Spain
关键词
bone turnover; haemodialysis; osteoprotegerin; phosphate removal; PTH; RANKL;
D O I
10.1093/ndt/gfl034
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. As the main mineral reservoir, bone acts as a calcium (Ca) and phosphate buffering system. Accordingly, phosphate removal by haemodialysis (HD) might be theoretically influenced by bone turnover, as well as by the interaction of regulatory molecules, such as PTH and osteoprotegerin (OPG). The present study investigated the relationship between these variables and phosphate removal by HD. Methods. Blood samples for serum Ca, phosphate, bicarbonate, intact PTH, PTH (1 - 84), bone alkaline phosphatase, tartrate-resistant acid phosphatase 5b, OPG and receptor activator of nuclear factor-kappa B ligand ( RANKL) were obtained in 28 HD patients. Phosphate removal was measured by a continuous collection of the dialysate. Results. Pre-dialysis serum phosphate concentration is the critical factor in determining dialytic phosphate removal. However, multiple regression analysis reveals that phosphate removal is better explained by a combination of factors than by phosphate concentration alone. In this model, the PTH/OPG ratio is an additional positive factor, whereas age and vitamin D treatment are negative factors. Patients with pre-HD bicarbonate higher than 20 mEq/l had higher serum phosphate and, accordingly, higher phosphate removal; of interest, these individuals also have significant differences in RANKL/OPG. Mean (SD) OPG levels were significantly higher than that in the healthy population (16.2 ( 12.5) pmol/ l; these values correlated with age (r = 0.4, P < 0.04). Mean serum RANKL (1.03 (1.02) pmol/l) was within the range of normal individuals. Conclusions. Dialytic phosphate removal has a crucial, direct relationship with pre-HD plasma phosphate levels. However, the phenomenon of phosphate removal is more precisely explained using a more complex relationship, defined by the interaction between serum phosphate, PTH/ OPG, age and vitamin D administration. Serum RANKL levels are first reported in HD patients, and are not different from the normal population.
引用
收藏
页码:1626 / 1632
页数:7
相关论文
共 50 条
  • [31] Association between bone turnover markers, bone mineral density and vitamin D in Moroccan postmenauposal women
    Elmaataoui, A.
    Idrissi, S. Elmachtani
    Dami, A.
    Bouhsain, S.
    Chabraoui, L.
    Ouzzif, Z.
    PATHOLOGIE BIOLOGIE, 2014, 62 (01): : 49 - 54
  • [32] Association between bone turnover markers and bone mineral density in puberty and constitutional delay of growth and puberty
    Doneray, H.
    Orbak, Z.
    WEST INDIAN MEDICAL JOURNAL, 2008, 57 (01): : 33 - 39
  • [33] Association Between Biochemical Markers of Bone Turnover and Bone Changes on Imaging: Data From the Osteoarthritis Initiative
    Deveza, Leticia A.
    Kraus, Virginia B.
    Collins, Jamie E.
    Guermazi, Ali
    Roemer, Frank W.
    Bowes, Michael
    Nevitt, Michael C.
    Ladel, Christoph
    Hunter, David J.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (08) : 1179 - 1191
  • [34] P1NP, b-CrossLaps and osteocalcin as biochemical markers of bone turnover in haemodialysis patients
    Pavlovic, D
    Vrkic, N
    BONE, 2005, 36 : S237 - S238
  • [35] Association Between Circulating Tumour Cells and Bone Turnover Markers in Patients With Breast Cancer and Bone Metastases on Treatment With Bisphosphonates (ZOMAR Study)
    Manso, L.
    Tusquets, I.
    De la Piedra, C.
    Crespo, C.
    Gomez, P.
    Calvo, L.
    Galve, E.
    Ruiz Borrego, M.
    Rifa, J.
    Barnadas, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S337 - S337
  • [36] Association between Circulating Tumor Cells and Bone Turnover Markers in patients with breast cancer and bone metastases on treatment with bisphosphonates (ZOMAR study)
    Manso, L.
    Barnadas, A.
    Tusquets, I.
    Crespo, C.
    Gomez, P.
    Calvo, L.
    Ruiz, M.
    Martinez, P.
    Perello, A.
    Anton, A.
    Codes, M.
    Margeli, M.
    Murias, A.
    Salvador, J.
    Segui, M. A.
    De Juan, A.
    Gavila, J.
    Luque, M.
    Perez, D.
    Zamora, P.
    Arizcum, A.
    Chacon, J. I.
    Heras, L.
    De la Piedra, C.
    CANCER RESEARCH, 2012, 72
  • [37] Effects of phosphate binders on bone biomarkers and bone density in haemodialysis patients
    Udomkarnjananun, Suwasin
    Phannajit, Jeerath
    Takkavatakarn, Kullaya
    Tumkosit, Monravee
    Kingpetch, Kanaungnit
    Avihingsanon, Yingyos
    Praditpornsilpa, Kearkiat
    Eiam-Ong, Somchai
    Susantitaphong, Paweena
    NEPHROLOGY, 2022, 27 (05) : 441 - 449
  • [38] Association of immune function with bone mineral density and biochemical markers of bone turnover in patients with anklylosing spondylitis
    Yilmaz, N
    Pence, S
    Kepekçi, Y
    Geyikli, I
    Özaslan, J
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (08) : 681 - 685
  • [39] Association between Biomarkers of Mineral and Bone Metabolism and Removal of Calcium and Phosphate in Hemodialysis
    Debowska, Malgorzata
    Dai, Lu
    Wojcik-Zaluska, Alicja
    Poleszczuk, Jan
    Zaluska, Wojciech
    Lindholm, Bengt
    Waniewski, Jacek
    BLOOD PURIFICATION, 2020, 49 (1-2) : 71 - 78
  • [40] Bone turnover markers in patients with osteogenesis imperfecta
    Braga, V
    Gatti, D
    Rossini, M
    Colapietro, F
    Battaglia, E
    Viaplana, O
    Adami, S
    BONE, 2004, 34 (06) : 1013 - 1016